-- China National Medicines' (SHA:600511) attributable profit rose 3.3% to 474.3 million yuan in the first quarter from 459 million yuan in the year-ago period, according to a Thursday filing with the Shanghai bourse.
Earnings per share at the pharmaceutical company increased 3.3% to 0.6286 yuan from 0.6084 yuan in the prior-year period.
Operating income grew 6.6% year over year to 13.6 billion yuan from 12.7 billion yuan.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We upgrade our rating to Buy (Hold) and raise the target price to USD16.00 (USD6.50) by rolling forward valuation metrics to 2027 and shifting to P/Sales (P/S) from EV/EBITDA. We apply a 3.25x P/S multiple based on Optical Network peers' five-year average on higher contribution from Optical Networks, stronger AI & Cloud demand visibility, and a more durable growth profile beyond the telecom cycle. The re-rating reflects improving earnings visibility and a structural shift in demand toward AI-driven infrastructure. While Q1 2026 results were in line with expectations, we raise 2026 revenue forecast to EUR21.5B (EUR21.1B) and 2027 to EUR23.3B (EUR22.6B) on higher Network Infrastructure growth guidance, improving supply visibility, and stronger order momentum. This also incorporates early backlog conversion and improving execution in Optical Networks. Hence, we increase 2026 EPS to EUR0.32 (EUR0.31) and 2027 to EUR0.39 (EUR0.37) on revenue mix improvement, with margin expansion expected as scale benefits materialize.
The US Department of the Interior on Wednesday released a final environmental review of a proposal to restart well stimulation, including hydraulic fracturing, at an aging oil platform off the coast of Southern California.The review, conducted by the Bureau of Ocean Energy Management, covers potential environmental impacts of treatments on up to 16 existing wells at Platform Gilda, located in federal waters off Ventura County in the Santa Barbara Channel.The work forms part of an update to the operator's Development and Production Plan for the platform, which has been in operation since 1981.BOEM said publication of the final environmental impact statement does not constitute approval of the proposed activities. The agency is expected to issue a separate record of decision after completing its review of environmental and other relevant considerations.Platform Gilda, operating under Outer Continental Shelf Lease No. P0216 is located about 8.8 miles or 14 kilometers southwest of Ventura, California, in waters about 205 feet deep.The platform, which was installed in 1981, has remained in continuous operation since then.
Tower Resources (TWR.V) received permit to resume diamond drilling on its Rabbit North orogenic gold discovery in the heart of the Kamloops porphyry copper (Cu) mining district, it said Thursday.Mobilization of the drill rig is underway. Fifteen new drill sites have been approved and drilling is planned at a minimum of ten sites with a possible second hole at some sites, it added.The company will extend hole 73 southeast to its targeted 300 meters depth. Its main focus will be on closing the untested gap between the Thunder North and Blue Sky gold zones and extending the Thunder zone westward.Tower Resources will also investigate historical gold intersection 1-kilometers northeast of Blue Sky.Shares of the company were last seen unchanged at $0.165 on the TSX Venture Exchange.